KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
NASDAQ:CERC
Delisted

Cerecor Inc. Stock Price (Quote)

$0.319
+0.0060 (+1.92%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $0.202 $0.502 Friday, 27th May 2022 CERC stock ended at $0.319. This is 1.92% more than the trading day before Thursday, 26th May 2022. During the day the stock fluctuated 9.33% from a day low at $0.300 to a day high of $0.328.
90 days $0.202 $0.94
52 weeks $0.202 $3.70

Historical Cerecor Inc. prices

Date Open High Low Close Volume
Jul 15, 2019 $4.97 $4.97 $4.78 $4.85 62 481
Jul 12, 2019 $5.21 $5.21 $4.91 $4.97 66 787
Jul 11, 2019 $5.39 $5.42 $5.12 $5.25 60 759
Jul 10, 2019 $5.37 $5.46 $5.29 $5.40 51 211
Jul 09, 2019 $5.23 $5.40 $5.23 $5.37 79 428
Jul 08, 2019 $5.38 $5.43 $5.15 $5.29 140 712
Jul 05, 2019 $5.41 $5.41 $5.25 $5.40 59 294
Jul 03, 2019 $5.10 $5.64 $5.10 $5.40 134 586
Jul 02, 2019 $5.64 $5.65 $5.00 $5.09 645 452
Jul 01, 2019 $5.53 $5.93 $5.38 $5.65 526 726
Jun 28, 2019 $4.85 $5.50 $4.75 $5.44 3 035 578
Jun 27, 2019 $4.90 $5.14 $4.80 $4.88 136 715
Jun 26, 2019 $4.99 $4.99 $4.81 $4.90 135 498
Jun 25, 2019 $4.97 $5.00 $4.80 $4.88 103 897
Jun 24, 2019 $4.97 $4.99 $4.74 $4.91 106 140
Jun 21, 2019 $4.95 $5.01 $4.68 $5.00 136 596
Jun 20, 2019 $5.07 $5.13 $4.90 $4.93 73 504
Jun 19, 2019 $5.15 $5.20 $4.93 $5.05 72 596
Jun 18, 2019 $5.31 $5.31 $5.05 $5.13 216 302
Jun 17, 2019 $5.35 $5.49 $5.15 $5.15 82 206
Jun 14, 2019 $5.69 $5.97 $5.30 $5.34 126 319
Jun 13, 2019 $5.42 $5.77 $5.39 $5.71 167 310
Jun 12, 2019 $5.21 $5.49 $5.21 $5.40 165 438
Jun 11, 2019 $5.00 $5.37 $4.90 $5.25 268 612
Jun 10, 2019 $4.86 $5.13 $4.63 $4.98 252 621
Click to get the best stock tips daily for free!

About Cerecor Inc.

Cerecor. Cerecor Inc., a clinical-stage biopharmaceutical company, develops drugs to treat patients with neurological and psychiatric disorders. It develops CERC-301 that is in Phase II development stage for the adjunctive treatment of patients with major depressive disorder (MDD); CERC-501, which is in Phase II development stage for the adjunctive treatment of MDD, as well as to treat substance use disorders; and CERC-406 that is in preclinical stage to ... CERC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT